Enhancing Crown Bioscience's Digital Presence through Specialised Science Writing and Data Visualisation
Crown Bioscience is a prominent global contract research organisation (CRO) that excels in providing cutting-edge services across discovery, preclinical, and translational platforms in oncology and immuno-oncology. With a mission deeply rooted in enhancing the development of oncological therapeutics, Crown Bioscience aimed to elevate its online presence to reflect its expertise and industry leadership.
expertise delivered
Acknowledging the need for specialised content that resonates with scientific professionals and stakeholders, Crown Bioscience partnered with Arttia Creative to access our expertise in life sciences content creation and copywriting. Arttia Creative was tasked to develop engaging and informative content enriched with robust data visualisations and optimised for search engines.
- In-depth research
- Content creation with a focus on oncology
- Scientific and medical copywriting
- Publishing, planning and scheduling
- Regular communications and publishing tracking
- 12 months of content support
- Scientific article copywriting
- White paper design
- Data visualisation
- SEO optimisation
- View pubished articles
Content creation - specialist scientific copywriting and data visualisation
Project Objective: To strengthen Crown Bioscience’s digital presence through high-quality, insightful content aligning with its mission to advance oncology and immuno-oncology research. Providing scientific and medical-focused copywriting and supporting graphics.
Background
Crown Bioscience is a prominent global contract research organisation (CRO) that excels in providing cutting-edge services across discovery, preclinical, and translational platforms in oncology and immuno-oncology.
With a mission to advance oncological therapeutics, Crown Bioscience sought to elevate its online presence to reflect its expertise and industry leadership.
Acknowledging the need for specialised content that resonates with scientific professionals and stakeholders, Crown Bioscience partnered with Arttia Creative. Known for our expertise in life sciences and digital marketing, Arttia Creative was tasked to create engaging and informative content enriched with robust data visualisations and optimised for search engines, over a 12-month period.
Challenge
The primary challenge was to produce content that was not only scientifically accurate but also engaging and accessible to a diverse audience, including industry experts, academic researchers, and potential clients in the biotech and pharma sectors. Furthermore, the content needed to be optimised for search engines to enhance visibility and drive targeted traffic to Crown Bioscience’s website.
Strategy
The approach taken by Arttia Creative involved several key phases:
- In-depth Research: Our team conducted extensive research to deeply understand the current advancements and trends in oncology and immuno-oncology. This allowed us to identify relevant topics that resonate with Crown Bioscience’s audiences and objectives.
- Content Creation with a Specialised Focus: Leveraging our expertise in life sciences,articles were crafted, offering unique insights and the latest findings relevant to oncology drugs and therapies. Each copywriting piece was tailored to reflect Crown Bioscience’s authoritative voice in the industry.
- Data Visualisations: When required, we incorporated custom data graphics to complement our insightful articles. These visual elements were designed to present complex scientific data in a more digestible and engaging format, facilitating better understanding and retention for readers.
- SEO Optimisations: Our SEO experts employed on-page strategies to ensure the copywriting and content were fully optimised for search engines.
Execution
The project delivered a 12-month publishing schedule of articles designed to help with the client's positioning and website traffic.
Results
The collaboration between Crown Bioscience and Arttia Creative yielded significant outcomes:
- Enhanced Engagement: The specialised content led to increased engagement among the target audience, as evidenced by longer page visits and lower bounce rates.
- Improved SEO Performance: The articles achieved higher search rankings for targeted keywords, boosting organic traffic.
- Elevated Brand Authority: By consistently producing high-quality, relevant content, Crown Bioscience has strengthened its position as a leader in oncology research.
Conclusion
Through strategic planning, expert execution, and continuous collaboration, Arttia Creative successfully enhanced Crown Bioscience’s digital footprint. This project exemplifies how specialised content, combined with SEO and data visualisation, can profoundly impact a science-focused organisation’s online presence and authority in a competitive industry.
View a range of articles written by the team at Arttia Creative and published by Crown Bioscience:
- The Role of Organoids in Antibody-Drug Conjugate Development
- Mastering the fight against drug resistance: how to choose and use the right models
- Antibody-drug conjugates: bridging precision and potency in oncology
- Transforming Cancer Therapy: Insights from 2025 FDA Approvals and Preclinical Drug Discovery
- The role of PDXs models in Antibody-Drug Conjugate Development.
- The next generation of antibody-drug conjugates: pan-cancer ADCs
- Off-target toxicity in antibody-drug conjugates
- Key assays and analytical techniques for the development of antibody-drug conjugates
- The Role of Organoids in Antibody-Drug Conjugate Development
- Top 5 quality factors that make or break biospecimen research
- Transforming Cancer Therapy: Insights from 2025 H1 FDA Approvals and Preclinical Drug Discovery
- Emerging Technologies in Biomarker Discovery You Should Know About
- Bridging the Gap: Translating Preclinical Biomarkers to Clinical Success
- How In Vitro DMPK Studies Can Prevent Late-Stage Drug Development Failures
- Integrating DMPK Early in Drug Development: A Strategic Imperative for Success
- The Future of Clinical Trials: Incorporating 'Omics for Enhanced Stratification
- How In Vitro DMPK Studies Can Prevent Late-Stage Drug Development Failures